Advanced BioScience Laboratories Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Advanced BioScience Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011794
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advanced BioScience Laboratories Inc (ABL), a subsidiary of Institut Merieux SA is a contract research and manufacturing company that provides services to life sciences industry. The company develops vaccines, therapeutics and other biologic products. It provides proof-of-concept in vivo studies with preclinical immunomonitoring, potency testing and efficacy. ABL’s services include technology transfer, upstream cell culture, and others. The company offers contract research services and contract manufacturing services, which include virus seed stock development, plaque purification, cGMP virus banking, viral lysate production, upstream process development, downstream purification development, production of toxicology supply and production of clinical supply. ABL is headquartered in Rockville, Maryland, the US.

Advanced BioScience Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Advanced BioScience Labs Acquires Production Asset of Transgene 10
Partnerships 11
ABL Enters into Contract Manufacturing Agreement with RegenxBio 11
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 12
Asset Transactions 13
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 13
Advanced BioScience Laboratories Inc – Key Competitors 15
Advanced BioScience Laboratories Inc – Key Employees 16
Advanced BioScience Laboratories Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
May 11, 2017: ABL Increases Aseptic Fill/Finish Capacity with State-of-the-Art, Fully Automated Vial Filling Line 18
Government and Public Interest 19
Jul 26, 2016: The Division of AIDS Awards ABL a Seven-Year Contract to Provide HIV Microbicide Research and Product Development Support 19
Mar 03, 2016: ABL Part of Team Awarded $900 Million IDIQ Contract by U.S. Army for Medical Product Research and Development 20
Other Significant Developments 21
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advanced BioScience Labs Acquires Production Asset of Transgene 10
ABL Enters into Contract Manufacturing Agreement with RegenxBio 11
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 12
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 13
Advanced BioScience Laboratories Inc, Key Competitors 15
Advanced BioScience Laboratories Inc, Key Employees 16
Advanced BioScience Laboratories Inc, Subsidiaries 17

★海外企業調査レポート[Advanced BioScience Laboratories Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Histogenics Corp (HSGX):医療機器:M&Aディール及び事業提携情報
    Summary Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weigh …
  • InDex Pharmaceuticals Holding AB (INDEX):企業の財務・戦略的SWOT分析
    Summary InDex Pharmaceuticals Holding AB (InDex Pharmaceuticals) is a pharmaceutical company that offers treatments for immunological diseases. The company’s lead compound cobitolimod, currently in the phase 2 stage, is intended for the treatment of moderate to severe treatment active refractory ulc …
  • Taiheiyo Cement Corporation:企業の戦略・SWOT・財務分析
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • M. Dias Branco SA Ind Com de Alimentos:企業の戦略・SWOT・財務情報
    M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report Summary M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • mixi, Inc.:企業の戦略・SWOT・財務情報
    mixi, Inc. - Strategy, SWOT and Corporate Finance Report Summary mixi, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Deutsche Borse Ag:企業の戦略・SWOT・財務分析
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sinclair Oil Corporation:企業の戦略・SWOT・財務情報
    Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company offers products such as automated nucleic acid isolation system, large sample volume nucleic acid extracti …
  • Ironshore, Inc.:企業の戦略・SWOT・財務情報
    Ironshore, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ironshore, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Canadian Broadcasting Corp:企業の戦略的SWOT分析
    Canadian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • The Capital Group Companies, Inc.:企業の戦略・SWOT・財務分析
    The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mitsubishi Motors Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • EnerMech Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary EnerMech Ltd (EnerMech) is a provider of oilfield services. The company offers cranes and lifting services, hydraulic products and services, pipeline and umbilicals services, valve services, equipment rental, training services and industrial services. Its pipeline and umbilical services comp …
  • Tivo Corporation:戦略・SWOT・企業財務分析
    Tivo Corporation - Strategy, SWOT and Corporate Finance Report Summary Tivo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nissan Motor Co Ltd (7201):企業の財務・戦略的SWOT分析
    Nissan Motor Co Ltd (7201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SomaLogic Inc:企業の製品パイプライン分析2018
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Proactis Holdings Plc (PHD):企業の財務・戦略的SWOT分析
    Summary Proactis Holdings PLC (Proactis) is a technology company. The company develops and provides spend control and eprocurement solutions. It offers various solutions such as purchase-to-pay, eCommerce, source-to-contract, and global framework. It provides source-to-contract solutions for supplie …
  • Jiangsu Jiuding New Material Co Ltd (002201):企業の戦略的SWOT分析
    Jiangsu Jiuding New Material Co Ltd (002201) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆